First, partial hematischesis therapy: Fibrin froth, gelatin sponge, zymoplasm, adrenalin and so on.
Second, substitution therapy
1st, loses the blood plasma: For the light case’s first choice therapy, inputs the 1000ml fresh blood plasma to be possible to cause the factor?The content enhances normally to 20-25%, an injection dosage is not suitable surpasses the 10-15ml/kg body weight.
2nd, cold settling: Freezes in the cold precipitation preparation each bag to contain the factor?Activeness is 100u equally, may cause the factor?The blood plasma changes thickly enhances normally to 50% above.
3rd, factor?, IX concentrating agent: For freezing and drying product, each unit’s factor?, IX activeness is equal in the 1ml normal person fresh blood plasma the average activeness, each kilogram body weight pours into 1u the factor?, may cause in vivo factor?Activeness elevates approximately 2%, but pours into the 1u factor IX only to enhance active 0.5-1%, must every 12 hours supplement one time, the early small hemorrhage uses 10u/kg generally namely effectively, factor?Or the factor IX concentrating agent substitution therapy’s dosage and the usage, the early mild hemorrhage, must supplement that 10u/kg body weight (only 1 time namely enough), the moderate hemorrhage, must supplement that the 20-25u/kg body weight (every 12 hour duplicate injection), the serious hemorrhage, must supplement the 40-50u/kg body weight (later every 12-24 hours will stop or the wound cicatrization for 20u-25u/kg until the hemorrhage. (this is safest at present, conveniently, effective method of treatment)
Third, other pharmacotherapy:
1st, suppresses the fibrinolysis medicine. 2nd, reaches that zuo. 3rd, the adrenal cortex hormone has certain curative effect.